In a significant move to address the systemic inefficiencies plaguing respiratory healthcare, AI-driven care coordination leader Viz.ai has unveiled the "Viz Pulmonary Suite." This comprehensive platform is designed to consolidate clinical workflows for three of the most critical pulmonary challenges—Chronic Obstructive Pulmonary Disease (COPD), lung nodules, and pulmonary embolism (PE)—into a singular, EHR-integrated ecosystem. By leveraging artificial intelligence to bridge the gaps between imaging, diagnosis, and treatment, the suite aims to solve the persistent problem of "lost patients" and improve long-term outcomes for millions of Americans.
The State of Pulmonary Care: A Crisis of Fragmentation
For the more than 34 million adults in the United States living with chronic lung disease, the journey through the healthcare system is often fraught with delays and communication breakdowns. The complexity of respiratory care means that patients frequently transition between emergency departments, imaging centers, and inpatient units, each of which often operates in a data silo.
According to industry data highlighted by Viz.ai, the human and economic costs of this fragmentation are staggering. Nearly 50% of patients hospitalized for acute COPD exacerbations face readmission within just 30 days, a statistic that underscores the failure to maintain consistent care post-discharge. Meanwhile, diagnostic gaps remain a major hurdle: up to 79% of incidental pulmonary embolisms—many of which are clinically significant—are missed during initial imaging review. Similarly, the follow-up rate for clinically significant lung nodules remains alarmingly low, with up to 71% of patients failing to receive the appropriate subsequent care required for early intervention.
The Viz Pulmonary Suite is engineered to address these "care gaps" by ensuring that critical clinical findings are not just identified, but acted upon through automated, context-aware workflows.
Chronology: From AI Concept to Clinical Reality
The development of the Viz Pulmonary Suite follows years of iterative advancements in AI-driven diagnostic imaging.
- Early Development: Viz.ai initially gained industry recognition for its AI-powered stroke detection software, which significantly reduced door-to-needle times for stroke patients. Recognizing the applicability of these algorithms to other acute, time-sensitive conditions, the company began internal R&D focused on respiratory health.
- Proof of Concept: The company utilized the "Viz PE" module as a beachhead, conducting clinical studies to validate the efficacy of AI-assisted detection in real-world hospital environments.
- Expansion of Scope: Recognizing that PE is only one part of the respiratory patient journey, the team expanded their platform to include lung nodule management and longitudinal monitoring for COPD.
- EHR Integration: The final phase involved the deep integration of these disparate modules into a unified suite that communicates directly with Electronic Health Records (EHR), removing the need for clinicians to toggle between platforms.
- The Announcement: The official unveiling of the suite precedes its upcoming demonstration at the American Thoracic Society (ATS) conference, scheduled for May 17-19, 2026.
Supporting Data: Efficacy and Outcomes
The value proposition of the Viz Pulmonary Suite is rooted in clinical evidence, particularly regarding the management of pulmonary embolisms.
In a notable single-center study, the implementation of Viz PE—the foundation of the suite’s PE workflow—demonstrated a dramatic improvement in patient safety and efficiency. The study revealed that the time to treatment for high-risk patients was slashed from 1.75 days to 0.56 days. Beyond the speed of intervention, the research indicated a direct correlation with clinical outcomes, showing a marked decrease in in-hospital mortality among high-risk patients.
These metrics provide a compelling case for hospitals to shift from manual, chart-based screening to automated, AI-driven surveillance. By removing the latency between a "positive" imaging scan and a physician’s decision-making process, the suite ensures that clinical guidelines are surfaced exactly when they are needed, rather than buried in static, retrospective reports.
Official Responses and Clinical Perspectives
The launch of the suite has been met with enthusiasm from medical leadership, who view this technology as a necessary evolution in respiratory care.
Tim Showalter, MD, Chief Medical Officer of Viz.ai, emphasized the human side of the technology, noting that the medical community often suffers from a lack of coordination rather than a lack of medicine. "Pulmonary care breaks down not because we lack treatments, but because patients may be lost between moments of care," Dr. Showalter stated. "Across COPD, pulmonary embolism, and lung nodules, critical findings are often identified but not acted on in time due to fragmented workflows. The Viz Pulmonary Suite brings identification, coordination, and follow-through into a single solution that is fully integrated with the EHR, helping clinicians intervene earlier and manage these patients with greater consistency."
Supporting this sentiment, Lakshman Swamy, MD, MBA, FCCP, Chief Pulmonologist at Monogram Health, highlighted the impact on the patient experience. "As patients move through imaging, the emergency room, and acute care visits, their journey often becomes fragmented," Dr. Swamy said. "Solutions like the Viz Pulmonary Suite provide clinical teams with connected AI-enabled workflows to help identify potential patients earlier, act more efficiently, and support more consistent follow-up across the care continuum."
Implications for the Future of Healthcare
The introduction of this suite signals a broader industry trend toward "intelligent care orchestration." By automating the identification of high-risk patients, the suite reduces the cognitive burden on radiologists and pulmonologists, allowing them to focus on complex decision-making rather than administrative triage.
1. Reducing Readmissions
By integrating COPD monitoring into the same suite as acute event tracking, hospitals can identify high-risk patients during acute exacerbations and flag them for closer post-discharge follow-up. This proactive approach is essential for hospital systems operating under value-based care models, where readmission penalties can significantly impact financial performance.
2. Standardizing Diagnostic Follow-up
The "missing nodule" problem has long been a source of diagnostic error and potential malpractice liability. By automating the follow-up loop, the Viz Pulmonary Suite ensures that incidental findings are captured, tracked, and scheduled for review, regardless of which department initially ordered the scan.
3. Improving Clinical Efficiency
In the high-pressure environment of the emergency room, the speed of information is critical. By surfacing clinical guidelines directly within the EHR, the platform helps standardize care across different provider skill levels. This ensures that a patient presenting at a community hospital receives the same level of diagnostic urgency as one at a major academic center.
Looking Ahead: The ATS 2026 Showcase
As the medical community prepares for the ATS 2026 meeting in May, the Viz Pulmonary Suite will be the subject of significant interest. The conference, which gathers the world’s leading respiratory experts, will serve as a platform for Viz.ai to demonstrate the interoperability of the suite.
For hospitals and health systems, the adoption of such technology represents a move toward a more resilient, data-driven model of pulmonary care. As AI continues to move from the periphery to the center of clinical workflows, the success of the Viz Pulmonary Suite will likely be measured not just by the speed of its algorithms, but by its ability to permanently close the gaps that have hindered pulmonary patient care for decades.
In conclusion, the launch of the Viz Pulmonary Suite marks a turning point in the management of chronic and acute lung conditions. By transforming fragmented, reactive care into a streamlined, proactive process, Viz.ai is positioning itself at the forefront of a revolution in digital health—one that prioritizes patient continuity and clinical excellence in equal measure.
